Martin Samuel Bates
SEC CIK 1709024 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | SVP, CFO | 32.9K | — | $3.47M | 14 | 2021-08-10 | 2026-01-02 |
Most active insiders at CLDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wright Richard M. | Former Off | — | $1.18M |
| 2 | Jimenez Freddy A. | SVP, GC | — | $121.2K |
| 3 | Martin Samuel Bates | SVP AND CFO | — | — |
| 4 | PEPIN RONALD | SVP, CBO | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | M - OptEx | $10.38 | +4,817 | 32.9K | +17% | +$50.0K |
| D | 2024-06-18 | 2024-06-14 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | S - Sale+OE | $35.42 | -17.2K | 28.1K | -38% | -$608.2K |
| DM | 2024-06-18 | 2024-06-14 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | M - OptEx | $10.16 | +20.2K | 28.3K | +247% | +$205.0K |
| D | 2024-06-03 | 2024-05-30 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | S - Sale+OE | $34.05 | -35.0K | 25.1K | -58% | -$1.19M |
| D | 2024-06-03 | 2024-05-30 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | M - OptEx | $10.38 | +25.0K | 60.1K | +71% | +$259.5K |
| D | 2024-01-04 | 2024-01-02 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | M - OptEx | $2.78 | +10.8K | 35.1K | +44% | +$29.9K |
| DM | 2022-08-15 | 2022-08-11+ | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | S - Sale+OE | $36.52 | -20.0K | 24.4K | -45% | -$730.4K |
| DM | 2022-08-15 | 2022-08-11+ | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP AND CFO | M - OptEx | $4.75 | +20.0K | 26.8K | +293% | +$95.1K |
| DM | 2021-12-28 | 2021-12-23 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP, CFO | M - OptEx | $5.68 | +7,000 | 33.9K | +26% | +$39.7K |
| D | 2021-12-28 | 2021-12-23 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP, CFO | S - Sale+OE | $42.00 | -9,500 | 24.4K | -28% | -$399.0K |
| DM | 2021-11-17 | 2021-11-15 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP, CFO | S - Sale+OE | $43.56 | -9,500 | 28.9K | -25% | -$413.9K |
| DM | 2021-11-17 | 2021-11-15 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP, CFO | M - OptEx | $5.68 | +7,000 | 36.4K | +24% | +$39.7K |
| DM | 2021-08-12 | 2021-08-10 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP, CFO | M - OptEx | $5.79 | +21.4K | 30.1K | +246% | +$123.7K |
| DM | 2021-08-12 | 2021-08-10 | CLDX | Celldex Therapeutics, Inc. | Martin Samuel Bates | SVP, CFO | S - Sale+OE | $45.25 | -2,738 | 29.4K | -9% | -$123.9K |
Purchase Sale Sale after option exercise All abbreviations